The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drug’s novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance. The post FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection appeared first on…
Rules restrict health plans from imposing greater restrictions on mental health or substance use disorder benefits than on medical and surgical benefits
By KIM BELLARD I hadn’t expected to write about a biology-related topic anytime soon after doing so last week, but, gosh darn it, then I saw a press release from Cornell about biohybrid robots – powered by mushrooms (aka fungi)! They had me at “biohybrid.” The release talks about a new paper — Sensorimotor…
This brief considers how default enrollment into Medicare Advantage might work, potential challenges with this approach, and implications for beneficiaries, insurers, providers, agents and brokers, and the federal budget.
Although proposed rule was wide-ranging, the final rule, which will be published on Dec. 16, contained only TEFCA-related items
KFF Health News senior correspondent Aneri Pattani discussed how mental health therapists are finding it difficult to work with insurance companies on WOSU Public Media’s “All Sides with Amy Juravich” on March 27. Click here to hear Pattani on “All Sides with Amy Juravich” KFF Health News national public health correspondent Amy Maxmen discussed the effects of…
Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 million up front to begin the collaboration. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on…
The decline in cognitive health, especially that leading to Alzheimer’s and other brain diseases, is one of the most feared conditions by patients and their families. It’s also one of the most expensive. But if we can predict it early there are things we can do to prevent or ameliorate it. The issue has been…
Federal officials resolved more than a decade ago to crack down on whopping government overpayments to private Medicare Advantage health insurance plans, which were siphoning off billions of tax dollars every year. But Centers for Medicare & Medicaid Services officials have yet to demand any refunds — and over the years the private insurance plans…
On October 8, 2024, Vice President Harris has proposed to expand Medicare to provide home care to help families who are struggling with the costs of long-term care. If enacted, this would be the first major expansion of Medicare since the Medicare Modernization Act of 2003 that added a prescription drug benefit to the program.